{"id":3318,"date":"2025-11-18T17:58:05","date_gmt":"2025-11-18T18:58:05","guid":{"rendered":"http:\/\/www.xinetica.com\/?p=3318"},"modified":"2025-11-20T14:38:45","modified_gmt":"2025-11-20T14:38:45","slug":"access-uncertain-for-new-injectable-prep-as-the-affordable-care-acts-aca-open-enrollment-begins","status":"publish","type":"post","link":"http:\/\/www.xinetica.com\/index.php\/2025\/11\/18\/access-uncertain-for-new-injectable-prep-as-the-affordable-care-acts-aca-open-enrollment-begins\/","title":{"rendered":"Access Uncertain for New Injectable PrEP as the Affordable Care Act\u2019s (ACA) Open Enrollment Begins"},"content":{"rendered":"<p>This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the drug widely being considered a major advance, early evidence suggests that insurance coverage and benefit design decisions may create barriers to access.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3320,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[15],"tags":[],"_links":{"self":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts\/3318"}],"collection":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/comments?post=3318"}],"version-history":[{"count":1,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts\/3318\/revisions"}],"predecessor-version":[{"id":3319,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts\/3318\/revisions\/3319"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/media\/3320"}],"wp:attachment":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/media?parent=3318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/categories?post=3318"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/tags?post=3318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}